ROR1 and cancer: The detection of soluble ROR1 in PF allows to distinguish NC from cancer patients (NC vs. PDAC (PER-), p = 0.0012; NC vs. PDAC (PER+), p = 0.0011), but not to differentiate PDAC (PER-) from PDAC (PER+).